What is the risk of synthetic cannabis?

In France, the sale of synthetic cannabis was recently banned. DP MP Gilles Baum asked the Minister of Health whether Luxembourg will also ban synthetic cannabis, how the risk to public health is assessed and whether the population should be made aware of synthetic cannabis and its risks.

Question

« Une loi interdisant la vente et la consommation de cannabinoïdes de synthèse est entrée en vigueur hier en France. Des médecins ont soutenu que la substance hexahydrocannabinol (HHC), qui est structurellement similaire au cannabinoïde naturel THC, doit être interdite en raison de ses effets psychoactifs. Selon mes informations, il est actuellement encore possible d’acheter et de consommer des produits contenant du HHC au Luxembourg.

Dans ce contexte, j’aimerais poser les questions suivantes à Madame la Ministre de la Santé :

  • Quelle est l’évaluation de votre ministère quant aux effets psychoactifs du HHC et à leur impact sur la santé publique ?
  • Madame la Ministre, avez-vous l’intention de suivre l’exemple français et d’interdire la vente du cannabinoïde de synthèse HHC?
  • Quelles initiatives le ministère de la santé envisage-t-il pour sensibiliser le public aux risques potentiels pour la santé liés à la consommation de produits contenant du HHC au Luxembourg, et comment les professionnels de la santé seront-ils soutenus ?
  • Comment le ministère de la santé prévoit-il de surveiller l’évolution de la situation liée aux cannabinoïdes de synthèse au Luxembourg et d’évaluer l’efficacité des mesures prises pour protéger la santé publique ?
  • Quel est l’état actuel de la recherche scientifique sur le HHC et les cannabinoïdes de synthèse, et comment ces données seront-elles prises en compte dans l’élaboration des politiques de réglementation ? »

Would you like this parliamentary question to be translated into English?

Share:

Facebook
Twitter
LinkedIn
Email
WhatsApp

More parliamentary questions

Administrative burden in primary education

Despite the Ministry of Education’s efforts to simplify administrative tasks in primary schools, unions point to a growing bureaucratic burden on teachers. What is the actual situation on the ground, and how might artificial intelligence play a role? A parliamentary question from our MPs Gilles Baum and Barbara Agostino seeks answers.

read more...

Second classroom support staff and A-EBS in cycle 1 of primary education

To ensure more effective pedagogical differentiation from the start of schooling, the coalition agreement foresees the gradual introduction of a second classroom support worker in cycle 1. This second staff member could also play a key role in the rollout of Project Alpha, especially in preparing children for literacy in German or French. Furthermore, assistants for pupils with special educational needs (A-EBS) are set to ease the workload of specialised teachers. Our MPs Gilles Baum and Barbara Agostino have submitted a parliamentary question to the Minister to clarify the implementation timeline and progress of these initiatives.

read more...

How many people suffer from anorexia?

In addition to obesity, anorexia is also a problem in our society. DP MPs André Bauler and Gilles Baum asked the Minister of Health, among other things, how many anorexia patients in Luxembourg had to be hospitalised, how long treatment lasts on average, and how treatment costs have developed over the last ten years.

read more...

No access to biological results in the LëtzHBM study?

As part of the LNS study ‘LëtzHBM’, biological and environmental samples are collected to determine the presence of chemical substances in private households. The results of the biological samples, unlike the environmental samples, are not systematically communicated to the participants.
DP MP Dr Gérard Schockmel has asked the Minister of Health why these results are not communicated and whether this is compatible with data protection regulations.

read more...